Abrysvo (RSVpreF) Respiratory Syncytial Virus Vaccine, Act-O-Vial, Single-Dose Vial, 10/Package

Abrysvo is a respiratory syncytial virus (RSV) vaccine indicated for the prevention of lower respiratory tract disease caused by RSV. This presentation contains 10 single-dose vials in an Act-O-Vial system, which allows for reconstitution of the lyophilized antigen with the supplied diluent. The vaccine is manufactured by Pfizer Inc.